Amplatzer
Payments companies reported to CMS as associated with Amplatzer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Amplatzer, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Amplatzer
These are the largest totals companies reported as associated with Amplatzer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Thomas Forbes | Detroit, MI | Pediatric Cardiology | $152,587.28 |
| Zahid Amin | Orlando, FL | Interventional Cardiology | $56,478.22 |
| Edwin I Perez Marrero | San Juan, PR | Interventional Cardiology | $40,219.81 |
| Howard Weber | Hershey, PA | Pediatric Cardiology | $37,606.76 |
| James Jenkins | New Orleans, LA | Interventional Cardiology | $33,773.42 |
| Michael Delaughter | Bedford, TX | Clinical Cardiac Electrophysiology | $28,749.77 |
| Dudley Holt | Austin, TX | Pediatric Cardiology | $26,233.12 |
| Sanjay Sinha | Orange, CA | Pediatric Cardiology | $18,766.91 |
| Jeffrey Delaney | Durham, NC | Pediatric Cardiology | $18,738.60 |
| Farhouch Berdjis | Aurora, CO | Pediatric Cardiology | $17,114.46 |
Prescribed Amplatzer?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.